Glenmark Pharmaceuticals
GLENMARK.NS
#2580
Rank
A$8.51 B
Marketcap
$30.18
Share price
0.73%
Change (1 day)
105.51%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand

Cash on Hand as of March 2024 : A$0.33 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company has A$0.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31A$0.26 B4.6%
2022-03-31A$0.25 B16.74%
2021-03-31A$0.21 B-14.33%
2020-03-31A$0.25 B10.16%
2019-03-31A$0.23 B-18.45%
2018-03-31A$0.28 B15.33%
2017-03-31A$0.24 B45.24%
2016-03-31A$0.16 B4.19%
2015-03-31A$0.16 B10.74%
2014-03-31A$0.14 B34.41%
2013-03-31A$0.10 B73.34%
2012-03-31A$62.71 M48.14%
2011-03-31A$42.33 M62.25%
2010-03-31A$26.09 M28.23%
2009-03-31A$20.34 M-52.61%
2008-03-31A$42.93 M41.62%
2007-03-31A$30.31 M-9.77%
2006-03-31A$33.59 M-11.04%
2005-03-31A$37.76 M1417.58%
2004-03-31A$2.48 M